全文获取类型
收费全文 | 3342篇 |
免费 | 177篇 |
国内免费 | 1篇 |
专业分类
3520篇 |
出版年
2021年 | 39篇 |
2019年 | 18篇 |
2018年 | 38篇 |
2017年 | 29篇 |
2016年 | 37篇 |
2015年 | 81篇 |
2014年 | 100篇 |
2013年 | 256篇 |
2012年 | 150篇 |
2011年 | 162篇 |
2010年 | 121篇 |
2009年 | 109篇 |
2008年 | 148篇 |
2007年 | 125篇 |
2006年 | 121篇 |
2005年 | 127篇 |
2004年 | 135篇 |
2003年 | 130篇 |
2002年 | 160篇 |
2001年 | 134篇 |
2000年 | 133篇 |
1999年 | 114篇 |
1998年 | 52篇 |
1997年 | 26篇 |
1996年 | 34篇 |
1995年 | 29篇 |
1994年 | 21篇 |
1993年 | 28篇 |
1992年 | 80篇 |
1991年 | 77篇 |
1990年 | 71篇 |
1989年 | 62篇 |
1988年 | 59篇 |
1987年 | 57篇 |
1986年 | 50篇 |
1985年 | 50篇 |
1984年 | 28篇 |
1983年 | 31篇 |
1982年 | 24篇 |
1981年 | 23篇 |
1980年 | 21篇 |
1979年 | 29篇 |
1978年 | 19篇 |
1977年 | 18篇 |
1976年 | 23篇 |
1975年 | 20篇 |
1974年 | 27篇 |
1973年 | 16篇 |
1969年 | 14篇 |
1968年 | 15篇 |
排序方式: 共有3520条查询结果,搜索用时 15 毫秒
991.
Makoto Niwa Keiko Enomoto Kouwa Yamashita 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》1999,729(1-2)
A sensitive LC–MS quantitation method of cetrorelix, a novel gonadotropin releasing hormone (GnRH) antagonist, was developed. Plasma and urine samples to which brominated cetrorelix was added as an internal standard (I.S.) were purified by solid-phase extraction with C8 cartridges. The chromatographic separation was achieved on a C18 reversed-phase column using acetonitrile–water–trifluoroacetic acid (35:65:0.1, v/v/v) as mobile phase. The mass spectrometric analysis was performed by electrospray ionization mode with negative ion detection, and the adduct ions of cetrorelix and I.S. with trifluoroacetic acid were monitored in extremely high mass region of m/z 1543 and 1700, respectively. The lower limit of quantitation was 1.00 ng per 1 ml of plasma and 2.09 ng per 2 ml of urine, and the present method was applied to the analysis of pharmacokinetics of cetrorelix in human during phase 1 clinical trial. 相似文献
992.
Yoshiharu Nishida Kenichi Hirano Kosuke Tsukamoto Makoto Nagano Chiaki Ikegami Kirsten Roomp Mitsuaki Ishihara Naoki Sakane Zhongyan Zhang Ken-ichi Tsujii Ki Akifumi Matsuyama Tohru Ohama Fumihiko Matsuura Masato Ishigami Naohiko Sakai Hisatoyo Hiraoka Hiroaki Hattori Cheryl Wellington Yoshihide Yoshida Susumu Misugi Michael R Hayden Toru Egashira Shizuya Yamashita Yuji Matsuzawa 《Biochemical and biophysical research communications》2002,290(2):713-721
ATP-binding cassette transporter-1 (ABCA1) gene is mutated in patients with familial high-density lipoprotein deficiency (FHD). In order to know the molecular basis for FHD, we characterized three different ABCA1 mutations associated with FHD (G1158A/A255T, C5946T/R1851X, and A5226G/N1611D) with respect to their expression in the passaged fibroblasts from the patients and in the cells transfected with the mutated cDNAs. Fibroblasts from the all patients showed markedly decreased cholesterol efflux to apolipoprotein (apo)-Al. In the fibroblasts homozygous for G1158A/A255T, the immunoreactive mass of ABCA1 could not be detected, even when stimulated by 9-cis-retinoic acid and 22-R-hydroxycholesterol. In the fibroblasts homozygous for C5946T/R1851X, ABCA1 mRNA was comparable. Because the mutant ABCA1 protein (R1851X) was predicted to lack the epitope for the antibody used, we transfected FLAG-tagged truncated mutant (R1851X/ABCA1-FLAG) cDNA into Cos-7 cells, showing that the mutant protein expression was markedly reduced. The expression of N1611D ABCA1 protein was comparable in both fibroblasts and overexpressing cells, although cholesterol efflux from the cells was markedly reduced. These data indicated that, in the three patients investigated, the abnormalities and dysfunction of ABCA1 occurred at the different levels, providing important information about the expression, regulation, and function of ABCA1. 相似文献
993.
Structure of the complex of the colicin E2 R-domain and its BtuB receptor. The outer membrane colicin translocon 总被引:2,自引:0,他引:2
Sharma O Yamashita E Zhalnina MV Zakharov SD Datsenko KA Wanner BL Cramer WA 《The Journal of biological chemistry》2007,282(32):23163-23170
The crystal structure of the complex of the BtuB receptor and the 135-residue coiled-coil receptor-binding R-domain of colicin E3 (E3R135) suggested a novel mechanism for import of colicin proteins across the outer membrane. It was proposed that one function of the R-domain, which extends along the outer membrane surface, is to recruit an additional outer membrane protein(s) to form a translocon for passage colicin activity domain. A 3.5-A crystal structure of the complex of E2R135 and BtuB (E2R135-BtuB) was obtained, which revealed E2R135 bound to BtuB in an oblique orientation identical to that previously found for E3R135. The only significant difference between the two structures was that the bound coiled-coil R-domain of colicin E2, compared with that of colicin E3, was extended by two and five residues at the N and C termini, respectively. There was no detectable displacement of the BtuB plug domain in either structure, implying that colicin is not imported through the outer membrane by BtuB alone. It was concluded that the oblique orientation of the R-domain of the nuclease E colicins has a function in the recruitment of another member(s) of an outer membrane translocon. Screening of porin knock-out mutants showed that either OmpF or OmpC can function in such a translocon. Arg(452) at the R/C-domain interface in colicin E2 was found have an essential role at a putative site of protease cleavage, which would liberate the C-terminal activity domain for passage through the outer membrane translocon. 相似文献
994.
995.
996.
997.
998.
Atsushi Yamaguchi Manabu Taniguchi Osamu Hori Satoshi Ogawa Nobuteru Tojo Nobuya Matsuoka Shin-ichi Miyake Kousuke Kasai Hisashi Sugimoto Michio Tamatani Toshihide Yamashita Masaya Tohyama 《The Journal of biological chemistry》2002,277(1):623-629
Emerging evidence has shown that tumor suppressor p53 expression is enhanced in response to brain ischemia/hypoxia and that p53 plays a critical role in the cell death pathway in such an acute neurological insult. However the mechanism remains unclear. Recently it was reported that Peg3/Pw1, originally identified as a paternally expressed gene, plays a pivotal role in the p53-mediated cell death pathway in mouse fibroblast cell lines. In this study, we found that Peg3/Pw1 expression is enhanced in peri-ischemic neurons in rat stroke model by in situ hybridization analysis, where p53 expression was also induced by immunohistochemical analysis. Moreover, we found that p53 was co-localized with Peg3/Pw1 in brain ischemia/hypoxia by double staining analysis. In human neuroblastoma-derived SK-N-SH cells, Peg3/Pw1 mRNA expression is enhanced remarkably at 24 h post-hypoxia, when p53 protein expression was also enhanced at high levels. Subcellular localization of Peg3/Pw1 was observed in the nucleus. Adenovirus-mediated high dose p53 overexpression induced Peg3/Pw1 mRNA expression. Overexpression of Peg3/Pw1 reduced cell viability under hypoxic conditions, whereas that of the C-terminal-deleted mutant and anti-sense Peg3/Pw1 inhibited hypoxia-induced cell death. These results suggest that Peg3/Pw1 is involved in the p53-mediated cell death pathway as a downstream effector of p53 in brain ischemia/hypoxia. 相似文献
999.
1000.